| Pfizer AG - FSME-Immun CC, Injektionssuspension in einer Fertigspritze | | 00450 | | 02 | | FSME-Immun CC | | Injektionssuspension in einer Fertigspritze | | J07BA01 | | Encephalitis, Tick Borne, Inactivated, Whole Virus | | 05.11.2001 | | |
| | Composition | | virus FSME inactivatus (Stamm Neudörfl) 2.4 µg, aluminii hydroxidum hydricum ad adsorptionem corresp. aluminium 0.35 mg, albuminum seri humani, natrii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.42 mg et kalium 0.013 mg, residui: saccharum, formaldehydum, protamini sulfas, neomycinum, gentamicinum. | | Packungsbestandteile | | | | | | | | | | Active Agent | Dose |
|---|
| | 2.4µg / 0.5ml |
| | BAG: Active Agent | Dose |
|---|
| | 2.4 mcg |
| | | | Inactive agents |
|---|
| Albuminum Seri Humani | | | | Disodium Phosphate Dihydrate | | Potassium Dihydrogenophosphate | | Sodium Chloride |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | Fertigspritze(n) | 27.00 | 45.80 | B | SL | No | | 004 | 10 Fertigspritze(n) | PR | PR | B | | No |
|
|
